| Bioactivity | BTA-9881 (MEDI-564) is a RSV inhibitor, with an EC50: 48 nM, 59 nM and 160 nM for RSV A2, RSV Long, and RSV B1. BTA-9881 has favorable pharmacokinetics property[1]. |
| CAS | 1646857-24-0 |
| Formula | C21H15ClN4O2 |
| Molar Mass | 390.82 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Bond S, et al. 1,2,3,9b-Tetrahydro-5H-imidazo[2,1-a]isoindol-5-ones as a new class of respiratory syncytial virus (RSV) fusion inhibitors. Part 2: identification of BTA9881 as a preclinical candidate. Bioorg Med Chem Lett. 2015 Feb 15;25(4):976-81. |
BTA-9881
CAS: 1646857-24-0 F: C21H15ClN4O2 W: 390.82
BTA-9881 (MEDI-564) is a RSV inhibitor, with an EC50: 48 nM,59 nM and 160 nM for RSV A2, RSV Long, and RSV B1. BTA-9881
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.